Member Info for aspex

There is little if any trading PBX on the Aquis platform.

The spread is horrendous . Up to 4p

There appears to be no access for Aquis Only shares on any international platforms.

The cost to move to AIM is quoted by SOH is up to £1m so based on 125m shares well under 1p for each share.

Liquidity is critical and Aquis does not perform or is ever likely to.

Time for the CEO to find a way out of this quagmire.

NOW!

O’Hara should have realised a long time ago that staying on Aquis restricts the share price notably on the spread but particularly that no international brokers include PBX as tradable.

That alone stops interest. Shares that are on Aquis as extra to their AIM listing for example are

unaffected. So for anyone outside UK has only expensive full service brokers to turn to and low flexibility.

It seems to be “Fiddling while Rome burns”

More promises.

Not much evidence of actual product

Costco is a bit of a ‘damp squib’ in NZ with only the one outlet in Auckland.. Optiman products in Chemist Warehouse and Bargain Chemist (best discount!)as well as one other nationwide group.

Not sure whether any Costco discount make enough price value to justify traffic snarls in Auckland.

Tata agreement using their ingredient.

Who is the winner?

Hmmmmm.

Presumably any morsels will be for open distribution?

There appears to be a missing word ‘a’ between the words ‘was patient’

;-))

May I offer my shameless advertising…..

Come and join me at ASX:BIT

Now time to chase SOH to send PBX on to AIM.

Has anyone thought of asking SOH for progress to AIM?

One week that suggested deadline.

Thanks, Elric. One question from the news item.

There is no differentiation over types of sweetener. It may well be that non-natural sweeteners are to blame but the comment does not specify so.

After the meteoric rise it is to be expected that today there would be a consolidation as the oberbulls settled and the day traders recognise that short term volatility becomes less rewarding.

30p or near seems a suitable base to take time to consider where we go and how quickly.

If the figures provided by the Professor have any credence and some more speedy reporting is offered my Management and not forgetting the AIM move by PBX, then I will be satisfied.

Now to settle back and relax for a month or three.

Without the RNS this looks like any comments can be taken with a pinch of salt because making any comment with actual figures puts the presenter in danger of offending the rules.

Without those details it is not worth wasting your time tuning in.

It is hard to see any worth in the presentation unless there is something to discuss.

So I expect a RNS.

Just hope for some ‘substantive’ details.

(‘Substantive’ is a SOH favourite though I don’t know if he understands its meaning ).

That conclusion is “lipstick on a pig” stuff….
…..unless something unpredictable actually occurred.
However the continuation of PBX on Aquis is totally unacceptable.

And what are Firmenich doing?

Very slow take up.
I just wonder whether Optipharm only took up the optibiome(slimbiome) option to hold back others like Bioslim and the
direct import of Gofigure and others.

But does not Coke Zero still contain Aspartame or one of the similar synthetic (I.e. non-natural) sweeteners?

In the light of this Sweetbiotix detail it would be interesting to see where the Firmenich deal links in, if at all.
Certainly it seems that progress is being made.
Still a bit frustrating.

Interesting booth site.
Right on a corner at the very end of the exhibits.
May or May not be a good thing.
We shall see.

AS. The Optipharm products are already on supermarket shelves in the area covered by FSANZ .
Just not enough shelf space.
It is ‘chicken and egg’ situation and would be helped enormously by prominent claim space on packaging.